- CCL2 Chemokine as a Potential Biomarker for Prostate Cancer: A Pilot Study
-
Tsaur I, Noack A, Makarevic , Oppermann , Waaga-Gasser AM, Gasser M, Borgmann H, Huesch T, Gust KM, Reiter M, Schilling , Bartsch G, Haferkamp , Blaheta RA
- KMID: 2132810
- Cancer Res Treat.
- 2015 Apr;47(2):306-312.
- doi: 10.4143/crt.2014.015
PURPOSE: Prostate specific antigen is not reliable in diagnosing prostate cancer (PCa), making the identification of novel, precise diagnostic biomarkers important. Since chemokines are associated with more aggressive disease and... -
- CITED
-
- Close
- SHARE
-
- Close
